PLSE Logo

Pulse Biosciences, Inc. (PLSE) 

NASDAQ
Market Cap
$1.11B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
37 of 776
Rank in Industry
2 of 48

Largest Insider Buys in Sector

PLSE Stock Price History Chart

PLSE Stock Performance

About Pulse Biosciences, Inc.

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in …

Insider Activity of Pulse Biosciences, Inc.

Over the last 12 months, insiders at Pulse Biosciences, Inc. have bought $9.77M and sold $0 worth of Pulse Biosciences, Inc. stock.

On average, over the past 5 years, insiders at Pulse Biosciences, Inc. have bought $25.03M and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: DUGGAN ROBERT W () — $28.64M. Levinson Mitchell E. (Chief Strategy Officer) — $105,090. Barrett Burke Thomas (President and CEO) — $85,600.

The last purchase of 10,000 shares for transaction amount of $85,600 was made by Barrett Burke Thomas (President and CEO) on 2024‑05‑20.

List of Insider Buy and Sell Transactions, Pulse Biosciences, Inc.

2024-05-20PurchasePresident and CEO
10,000
0.0181%
$8.56$85,600+90.75%
2023-12-12Purchase
17,999
0.0321%
$9.15$164,691+10.39%
2023-12-11Purchase
90,118
0.1681%
$9.36$843,504+13.88%
2023-12-08Purchase
116,656
0.2146%
$9.54$1.11M+8.32%
2023-12-07Purchase
74,852
0.1352%
$9.19$687,890+10.96%
2023-12-06Purchase
82,813
0.1516%
$9.06$750,286+14.00%
2023-12-05Purchase
66,021
0.1193%
$9.34$616,636+10.43%
2023-12-04Purchase
27,000
0.0505%
$10.38$280,260-0.10%
2023-12-01Purchase
45,600
0.0819%
$9.07$413,592+11.83%
2023-11-30Purchase
152,944
0.2765%
$9.06$1.39M+12.14%
2023-11-29Purchase
218,600
0.4025%
$9.38$2.05M+9.58%
2023-11-28Purchase
124,397
0.2339%
$8.98$1.12M+15.45%
2023-11-17Purchase
20,241
0.037%
$6.10$123,470+62.91%
2023-11-16PurchaseChief Executive Officer
5,393
0.0102%
$6.52$35,156+58.95%
2023-11-15PurchaseChief Strategy Officer
17,800
0.0298%
$5.90$105,090+54.67%
2023-05-09Purchase
10.02M
21.7052%
$6.51$65.25M-9.70%
2022-10-07PurchaseChief Strategy Officer
30,780
0.1025%
$2.27$69,908+96.52%
2022-09-30PurchaseChief Executive Officer
6,500
0.0192%
$2.30$14,950+62.61%
2021-06-30Purchase
3.05M
10.2958%
$16.40$50M-9.36%
2020-06-23Purchasedirector
1,193
0.0055%
$10.70$12,767+63.04%

Insider Historical Profitability

10.87%
DUGGAN ROBERT W
36984179
60.1206%
$18.07440+1.23%
Levinson Mitchell E.Chief Strategy Officer
73027
0.1187%
$18.0730+57.59%
Danahy Kevin PatrickChief Executive Officer
35887
0.0583%
$18.0720+62.61%
Barrett Burke ThomasPresident and CEO
10000
0.0163%
$18.0710
Zanganeh Makydirector
106767
0.1736%
$18.07170+19.34%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$9.1M1.711.04M-2.51%-$234,542.86<0.0001
The Vanguard Group$7.38M1.38847,212+28.76%+$1.65M<0.0001
Bank of America$6.79M1.27779,552-2.72%-$189,782.19<0.01
Geode Capital Management$3.41M0.64390,959+3.08%+$101,918.82<0.0001
State Street$3.05M0.57349,740+12.99%+$350,316.15<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.